Aptose Biosciences Inc.
Calidad de datos: 83%
APTOF
OTC
Manufacturing
Chemicals
$1.71
▲
$0.03
(1.79%)
Cap. Mercado: 4.41 M
Precio
$1.71
Cap. Mercado
4.41 M
Rango del Día
$1.71 — $1.73
Rango de 52 Semanas
$0.64 — $2.50
Volumen
186
Apertura $1.71
Promedio 50D / 200D
$1.63
4.83% above
Promedio 50D / 200D
$1.43
19.76% above
Quick Summary
Puntos Clave
Negative free cash flow of -21.99 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio0.53
Interest CoverageN/A
Valoración
PE (TTM)
-0.17
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.2 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -25.47 M |
| ROE | N/A | ROA | -426.89% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -21.99 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.53 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -3.30 M | Tangible Book Value | -19.45 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.17 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -498.66% | ||
| Market Cap | 4.41 M | Enterprise Value | 3.80 M |
| Per Share | |||
| EPS (Diluted TTM) | -10.41 | Revenue / Share | N/A |
| FCF / Share | -8.53 | OCF / Share | -8.53 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 86.34% |
| SBC-Adj. FCF | -22.41 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -25.47 M | -25.43 M | -51.21 M | -41.82 M | -65.35 M |
| EPS (Diluted) | -10.41 | -36.38 | -7.58 | -0.45 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 11.34 M | 15.10 M | 33.27 M | 28.09 M | 45.99 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 88,000.0 | 120,000.0 | 150,000.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | 0.0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10.01 M | 10.13 M | 12.99 M | 51.03 M | 82.53 M |
| Total Liabilities | 37.18 M | 14.67 M | 15.89 M | 13.29 M | 8.29 M |
| Shareholders' Equity | -27.17 M | -4.54 M | -2.90 M | 37.74 M | 74.24 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 935,000.0 | 6.15 M | 9.25 M | 36.97 M | 39.11 M |
| Current Assets | 6.45 M | 9.53 M | 11.89 M | 49.52 M | 81.74 M |
| Current Liabilities | 9.31 M | 4.46 M | 15.27 M | 12.28 M | 8.17 M |
{"event":"ticker_viewed","properties":{"ticker":"APTOF","listing_kind":"stock","pathname":"/stocks/aptof","exchange":"OTC","country":"US"}}